The AMR Centre, a body with public and private investors leading the UK’s response to the global health threat posed by antimicrobial resistance, has received a significant funding package to support the expansion of its pipeline of new drugs to treat drug-resistant infections.
22 March, 2019
Servier has entered into a collaborative study with Harvard University researchers to explore a new avenue for the treatment of type 2 diabetes and nonalcoholicfatty liver disease (NAFLD).
21 March, 2019
Save the date for the UK’s only lab-dedicated exhibition showcase!
19 March, 2019